Prim SA

Prim SA maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating a low reliance on debt financing. The company's liquidity position is characterized by a current ratio of 2.99, suggesting strong short-term liquidity. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, Prim SA reports a return on equity (ROE) of 12.12% and a return on assets (ROA) of 8.49%. These figures are to be compared against the industry's preferred metrics, which typically emphasize operational efficiency and consistent revenue generation. The company's operating income of 22,075,470 EUR and net income of 16,683,360 EUR reflect a healthy margin, but the extent to which these compare to industry medians remains to be determined. Prim SA's revenue is primarily derived from its core operations in the medical equipment and supplies sector, with no specific geographic or segment breakdown provided in the available data. The absence of detailed segmental or geographic revenue data limits the ability to assess exposure to specific markets or product lines. The company's growth trajectory is supported by a positive free cash flow of 8,002,480 EUR and a capital expenditure of -12,317,900 EUR, indicating a net outflow for capital investments. Analysts have assigned a mean recommendation of 1.00, which is the highest score on the scale, suggesting strong confidence in the company's future performance. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's dilution potential is considered low, and no significant adjustments have been applied to the valuation metrics. The absence of recent filings or transcripts prevents a detailed analysis of recent events that could impact the company's operations or financial position.